Histologic correlates of glandular abnormalities in cervical cytology among women with human immunodeficiency virus
- PMID: 20168108
- PMCID: PMC3032588
- DOI: 10.1097/AOG.0b013e3181bc6ce0
Histologic correlates of glandular abnormalities in cervical cytology among women with human immunodeficiency virus
Abstract
Objective: To estimate the frequency and histologic correlates of glandular abnormalities in cervical cytology among women with the human immunodeficiency virus (HIV) and to compare findings with those of women without HIV.
Methods: In a cohort study of HIV-infected and uninfected women followed between 1994 and 2007, Pap tests were obtained every 6 months. Glandular abnormalities, including atypical glandular cells (AGC), adenocarcinoma in situ (AIS), and adenocarcinoma, were identified and correlated with biopsy histology. Multivariate models to summarize data across visits used generalized estimating equations. The association of Pap and histology results was assessed using chi tests.
Results: Of 48,362 Pap tests from 3,766 women, glandular abnormalities were found in 341 (0.7%) tests from 244 (6%) women, including 93 (1.0%) of 9,564 Pap tests among HIV-seropositive women with CD4 lymphocyte counts less than 250/mm, 103 (0.8%) of 13,023 tests among those with counts 250-500/mm, 68 (0.6%) of 12,470 tests among women with counts greater than 500/mm, and 70 (0.6%) of 11,769 tests among HIV-seronegative women (P for trend=.006). Colposcopy was documented for only 148 (61%) of 244 index Pap tests in women with glandular abnormalities. After index abnormal tests, endocervical curettings were obtained from 106 (43%) women, cervical biopsies from 76 (38%), and endometrial biopsies from 19 (8%). Squamous lesions predominated among histologic findings and histology results did not differ by HIV serostatus (P=.16).
Conclusion: Although immunosuppression increased the risk of glandular Pap test abnormalities in women with HIV, these remained uncommon. Compliance with management guidelines can improved.
Level of evidence: II.
Similar articles
-
Accuracy of Papanicolaou test among HIV-infected women.Clin Infect Dis. 2006 Feb 15;42(4):562-8. doi: 10.1086/499357. Epub 2006 Jan 13. Clin Infect Dis. 2006. PMID: 16421802
-
Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV) testing.J Am Soc Cytopathol. 2024 May-Jun;13(3):227-232. doi: 10.1016/j.jasc.2024.01.004. Epub 2024 Jan 29. J Am Soc Cytopathol. 2024. PMID: 38401997
-
Lack of adherence to practice guidelines for women with atypical glandular cells on cervical cytology.Obstet Gynecol. 2005 Mar;105(3):501-6. doi: 10.1097/01.AOG.0000153489.25288.c1. Obstet Gynecol. 2005. PMID: 15738015
-
Clinical significance of atypical glandular cells on cervical cytology.Obstet Gynecol. 2006 Mar;107(3):701-8. doi: 10.1097/01.AOG.0000202401.29145.68. Obstet Gynecol. 2006. PMID: 16507944 Review.
-
Atypical glandular cells.Clin Obstet Gynecol. 2013 Mar;56(1):35-43. doi: 10.1097/GRF.0b013e3182823849. Clin Obstet Gynecol. 2013. PMID: 23314725 Review.
Cited by
-
Epidemiology of Cervical Adenocarcinoma and Squamous Cell Carcinoma Among Women Living With Human Immunodeficiency Virus Compared With the General Population in the United States.Clin Infect Dis. 2022 Mar 9;74(5):814-820. doi: 10.1093/cid/ciab561. Clin Infect Dis. 2022. PMID: 34143885 Free PMC article.
References
-
- Massad LS, Seaberg EC, Wright RL, Darragh T, Lee YC, Colie C, et al. Squamous cervical lesions in women with Human Immunodeficiency Virus: long-term follow up. Obstet Gynecol. 2008;111:1388–93. - PubMed
-
- Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in Human Immunodeficiency Virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst. 1999;91:226–36. - PubMed
-
- Delmas MC, Larsen C, van Benthem B, Hamers FF, Bergeron C, Poveda JD, et al. for the European Study Group on Natural History of HIV Infection in Women. Cervical squamous intraepithelial lesions in HIV-infected women: Prevalence, incidence and regression. AIDS. 2000;14:1775–84. - PubMed
-
- Serraino D, Carrieri P, Pradier C, Bidoli E, Dorrucci M, Ghetti E, et al. Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer. 1999;82:334–7. - PubMed
Publication types
MeSH terms
Grants and funding
- UO1-HD-32632/HD/NICHD NIH HHS/United States
- UO1-AI-34994/AI/NIAID NIH HHS/United States
- UO1-AI-34989/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- UO1-AI-35004/AI/NIAID NIH HHS/United States
- UO1-AI-34993/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- R01-CA-085178/CA/NCI NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- UO1-AI-31834/AI/NIAID NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- UO1-AI-42590/AI/NIAID NIH HHS/United States
- R01 CA085178/CA/NCI NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States